[go: up one dir, main page]

PE20040961A1 - Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel - Google Patents

Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel

Info

Publication number
PE20040961A1
PE20040961A1 PE2004000352A PE2004000352A PE20040961A1 PE 20040961 A1 PE20040961 A1 PE 20040961A1 PE 2004000352 A PE2004000352 A PE 2004000352A PE 2004000352 A PE2004000352 A PE 2004000352A PE 20040961 A1 PE20040961 A1 PE 20040961A1
Authority
PE
Peru
Prior art keywords
epinastin
vitamin
acid
compositions including
treatment
Prior art date
Application number
PE2004000352A
Other languages
English (en)
Inventor
Minoru Okada
Akira Takahashi
Norimitsu Umehara
Tetsuo Hayashi
Yoichi Onuki
Kazuki Matsumoto
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03008989A external-priority patent/EP1468696A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20040961A1 publication Critical patent/PE20040961A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSICIONES QUE COMPRENDEN: 1)EPINASTINA O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ESTA COMO COMPUESTO ACTIVO; Y AL MENOS, 2)UN COMPUESTO ADICIONAL SELECCIONADO DE: i)UNO O MAS AMINOACIDOS O PEPTIDOS QUE CONTIENEN AZUFRE, SELECCIONADOS DE: CISTEINA, METIONINA, ACIDO AMINOETILSULFONICO, GLUTATION, CISTINA, HOMOCISTEINA, HOMOCISTINA, ACIDO CISTEINASULFINICO Y/O LANTIONINA; ii)VITAMINAS DEL GRUPO B; iii)VITAMINAS CON PROPIEDADES ANTIOXIDANTES, SELECCIONADOS DE: VITAMINA C, VITAMINA E, VITAMINA A Y/O SUSTANCIAS ACTIVAS SIMILARES A LAS MISMAS; Y, iv)COMPUESTOS ANTIFLOGISTICOS, SELECCIONADOS DE: ACIDO GLICIRRICINICO, GLICIRRICINA, Y/O UNA SAL DE ESTE, ACIDO GLICIRRETINICO Y/O UN DERIVADO DE ESTE TAL COMO GLICIRRETINATO DE GLICERILO Y/O GLICIRRETINATO DE ESTEARILO Y/O ACIDO TRANEXAMICO Y/O UNA SAL DE ESTE
PE2004000352A 2003-04-04 2004-04-02 Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel PE20040961A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03007759 2003-04-04
EP03007779 2003-04-04
EP03007778 2003-04-04
EP03008989A EP1468696A1 (en) 2003-04-17 2003-04-17 Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases

Publications (1)

Publication Number Publication Date
PE20040961A1 true PE20040961A1 (es) 2005-01-05

Family

ID=33136052

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000352A PE20040961A1 (es) 2003-04-04 2004-04-02 Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel

Country Status (6)

Country Link
US (1) US20040247686A1 (es)
JP (1) JP2006522053A (es)
AR (1) AR044209A1 (es)
PE (1) PE20040961A1 (es)
TW (1) TW200501963A (es)
WO (1) WO2004087167A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
DE102005001645A1 (de) * 2005-01-13 2006-07-20 Gerhard Dr. Sauermann Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis
JP2009500397A (ja) * 2005-07-08 2009-01-08 千寿製薬株式会社 エピナスチンを含む眼科用経皮吸収型製剤
IL172896A0 (en) * 2005-12-29 2006-06-11 Yeda Res & Dev Cxcr4 inhibition
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
JP4300370B2 (ja) * 2007-03-13 2009-07-22 春三 小林 上皮改善剤
WO2008148573A2 (de) * 2007-06-08 2008-12-11 Bayer Consumer Care Ag Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen
FR2918876B1 (fr) * 2007-07-16 2012-10-05 Oreal Utilisation de lumiere verte pour activer la l-amino acide oxydase
DE102008006394A1 (de) * 2008-01-28 2009-07-30 Beiersdorf Ag Verwendung von Wirkstoffkomplexen aus Panthenol, Glycerin, Citrat und/oder Bisabolol gegen Pollenallergien
EP3744729B1 (en) * 2009-01-16 2023-03-01 Sederma Peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
US20140220136A1 (en) * 2013-02-05 2014-08-07 Bordoloi Biotech, Llc System and method for delivering protease inhibitors
MX368853B (es) * 2014-07-01 2019-10-18 CHACON Enrique Composiciones y métodos tópicos para el tratamiento de heridas.
PL238310B1 (pl) * 2017-10-31 2021-08-09 Top Energy Set Spolka Z Ograniczona Odpowiedzialnoscia Preparat leczniczy oraz sposób jego uzyskiwania
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
TW202241449A (zh) * 2020-12-24 2022-11-01 日商參天製藥股份有限公司 含有依匹斯汀(epinastine)或其鹽之塗敷投與用醫藥組合物
CN112915084B (zh) * 2021-04-13 2022-08-02 陕西医药控股医药研究院有限公司 一种治疗老年性皮肤瘙痒症的药物组合物及外用制剂
JP2023066490A (ja) * 2021-10-29 2023-05-16 花王株式会社 経口用顆粒組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
US20020103137A1 (en) * 1997-03-30 2002-08-01 Shiseido Co., Ltd. Method of treating environmental stress
JPH11158025A (ja) * 1997-09-26 1999-06-15 Shiseido Co Ltd 皮膚外用剤
JPH11100320A (ja) * 1997-09-29 1999-04-13 Risuburan:Kk 皮膚外用剤
JP4016128B2 (ja) * 1999-09-09 2007-12-05 東和薬品株式会社 耐光性塩酸エピナスチンフィルムコート錠
JP2001097888A (ja) * 1999-09-28 2001-04-10 Hiroshi Ikeno 外用組成物
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2003002125A2 (en) * 2001-06-29 2003-01-09 Astion A/S Combination of aminosugars and cysteine or cysteine derivatives
JP2003026608A (ja) * 2001-07-10 2003-01-29 Nof Corp 皮膚外用剤組成物
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration

Also Published As

Publication number Publication date
US20040247686A1 (en) 2004-12-09
TW200501963A (en) 2005-01-16
WO2004087167A3 (en) 2004-11-25
WO2004087167A2 (en) 2004-10-14
JP2006522053A (ja) 2006-09-28
AR044209A1 (es) 2005-09-07

Similar Documents

Publication Publication Date Title
PE20040961A1 (es) Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel
EP4442241A3 (en) Retinol replacement in skin treatment
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
EA201070940A1 (ru) Жидкая лекарственная форма фсг
PT812588E (pt) Composicao farmaceutica externa para administracao topica contendo 2-amino-2-(2-(4-octilfenil)-etil)-propano-1,3-diol para o tratamento de doencas provocadas por uma afeccao imunitaria
MXPA02011303A (es) Nueva composicion farmaceutica.
RU2016135952A (ru) Композиции ингибитора дофа-декарбоксилазы
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
JP2006522053A5 (es)
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
BRPI0408299A (pt) inibidores de catepsina s
UY32600A (es) Formulación en lípidos de un promotor de la apoptosis
AR039895A1 (es) Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla
CO2023002650A2 (es) Formas farmacéuticas sólidas de palbociclib
CN101945886A (zh) 采用含有脂质修饰半胱氨酸的肽的局部组合物和方法
AR037496A1 (es) Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables
EA201101246A1 (ru) Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение
UY29823A1 (es) Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
UY26911A1 (es) Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa
AR036591A1 (es) Uso de la hl en hiperestimulacion ovarica controlada
BR0314651A (pt) Composição farmacêutica, e, método para tratar infecção pelo hvi
ECSP13012369A (es) Agentes terapéuticos 976
CL2004000733A1 (es) Composicion farmaceutica que comprende epinastina y un compuesto adicional seleccionado de aminoacidos o peptidos que contienen azufre, vitaminas del grupo b, vitaminas con propiedades antiooxidantes y compuestos antiflogisticos, util en enfermedades
SE9904132D0 (sv) Pharmaceutical composition for treatment of diarrhea

Legal Events

Date Code Title Description
FA Abandonment or withdrawal